• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非胸腺瘤性儿童眼肌型重症肌无力的CT鉴别与特征分析

Differentiation and characterization of non-thymomatous ocular myasthenia gravis children with CT.

作者信息

Cai Youran, Cheng Zhongyuan, Yang Yuanting, Xu Baojun, Feng Qiwen, Liu Xu, Chen Jian, Zhou Qing

机构信息

Department of Ophthalmology, the First Affiliated Hospital of Jinan University, Guangzhou, China.

Department of Radiology, the First Affiliated Hospital of Jinan University, Guangzhou, China.

出版信息

Acta Neurol Belg. 2025 Feb;125(1):149-156. doi: 10.1007/s13760-024-02669-9. Epub 2024 Oct 30.

DOI:10.1007/s13760-024-02669-9
PMID:39476226
Abstract

PURPOSE

To compare thymic features using unenhanced computed tomography (CT) images between children with non-thymomatous ocular myasthenia gravis (OMG) and healthy children and determine the image feature cut-off values to allow differentiation of the two populations.

METHODS

We conducted a retrospective study involving 66 children who underwent chest CT, with 33 having non-thymomatous OMG and 33 healthy children without any abnormality. We recorded CT features of the thymus in each child, including the mean CT attenuation value, thymus area, area ratio, anteroposterior (AP) length, width (W), thickness (T), and transverse diameter (TD). These characteristics were analyzed to distinguish OMG from healthy controls. The receiver operating characteristic (ROC) analysis was used to clarify the best assessment, and the optimal cut-off values were determined.

RESULTS

The mean CT attenuation value, the thymus area, area ratio, and TD were significantly different (P < 0.05) between the two groups. The mean CT attenuation value was the most significant characteristic in differentiating OMG and healthy controls (area under the curve [AUC] = 0.70). Using 50.41 as the cut-off value for mean CT attenuation, a specificity of 0.70 and sensitivity of 0.82 was observed for distinguishing the two groups (P = 0.003). Optimal differentiation was achieved by combining more than one characteristic including CT attenuation, thymus area, and TD with an optional area ratio (AUC = 0.72).

CONCLUSIONS

Non-enhanced CT of the thymus complemented the clinical workup of children with non-thymomatous OMG. The cut-off values of the CT features may allow robust differentiation of OMG children.

摘要

目的

利用平扫计算机断层扫描(CT)图像比较非胸腺瘤性眼肌型重症肌无力(OMG)患儿与健康儿童的胸腺特征,并确定能够区分这两类人群的图像特征截断值。

方法

我们进行了一项回顾性研究,纳入了66例接受胸部CT检查的儿童,其中33例为非胸腺瘤性OMG患儿,33例为无任何异常的健康儿童。我们记录了每个儿童胸腺的CT特征,包括平均CT衰减值、胸腺面积、面积比、前后径(AP)、宽度(W)、厚度(T)和横径(TD)。分析这些特征以区分OMG患儿与健康对照。采用受试者操作特征(ROC)分析来明确最佳评估方法,并确定最佳截断值。

结果

两组之间的平均CT衰减值、胸腺面积、面积比和TD存在显著差异(P < 0.05)。平均CT衰减值是区分OMG患儿与健康对照的最显著特征(曲线下面积[AUC] = 0.70)。以50.41作为平均CT衰减的截断值,区分两组时观察到特异性为0.70,敏感性为0.82(P = 0.003)。通过结合包括CT衰减、胸腺面积和TD以及可选的面积比等多个特征可实现最佳区分(AUC = 0.72)。

结论

胸腺的平扫CT补充了非胸腺瘤性OMG患儿的临床检查。CT特征的截断值可能有助于对OMG患儿进行可靠的区分。

相似文献

1
Differentiation and characterization of non-thymomatous ocular myasthenia gravis children with CT.非胸腺瘤性儿童眼肌型重症肌无力的CT鉴别与特征分析
Acta Neurol Belg. 2025 Feb;125(1):149-156. doi: 10.1007/s13760-024-02669-9. Epub 2024 Oct 30.
2
Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment.CT与化学位移磁共振成像在鉴别重症肌无力患者胸腺瘤与非胸腺瘤性疾病中的比较:定性和定量评估的价值
Clin Radiol. 2016 Mar;71(3):e157-69. doi: 10.1016/j.crad.2015.12.009. Epub 2016 Jan 7.
3
Comparative study of computed tomography of normal and lymphoid follicular hyperplasia thymus in myasthenia gravis patients.重症肌无力患者正常胸腺与淋巴滤泡增生胸腺的计算机断层扫描对比研究。
Exp Ther Med. 2019 Jan;17(1):512-518. doi: 10.3892/etm.2018.6948. Epub 2018 Nov 9.
4
Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravis.胸腺脂肪瘤型重症肌无力手术治疗后的结局分析:与胸腺瘤型和非胸腺瘤型重症肌无力的比较
Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):475-81. doi: 10.1093/icvts/ivt531. Epub 2013 Dec 22.
5
CT-guided percutaneous ethanol injection of the thymus for treatment of myasthenia gravis.CT引导下经皮乙醇注射胸腺治疗重症肌无力
AJR Am J Roentgenol. 2003 Sep;181(3):721-4. doi: 10.2214/ajr.181.3.1810721.
6
Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy.重症肌无力中的胸腺:胸腺切除术后CT与病理结果及临床结局的比较
Radiology. 1996 Nov;201(2):471-4. doi: 10.1148/radiology.201.2.8888243.
7
Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.学术性神经眼科诊所中的眼肌型重症肌无力:临床特征与治疗反应
J Clin Neuromuscul Dis. 2011 Sep;13(1):46-52. doi: 10.1097/CND.0b013e31821c5634.
8
Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.胸腺切除术治疗非胸腺瘤型眼肌型重症肌无力患者的疗效:系统评价和荟萃分析。
Neurol Sci. 2017 Oct;38(10):1753-1760. doi: 10.1007/s10072-017-3058-7. Epub 2017 Jul 13.
9
Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.成人眼肌型重症肌无力转化:中国单中心回顾性分析。
Eur Neurol. 2020;83(2):182-188. doi: 10.1159/000507853. Epub 2020 Jun 11.
10
The Value of CT and MRI for Determining Thymoma in Patients With Myasthenia Gravis.CT 和 MRI 对重症肌无力患者胸腺瘤的诊断价值。
Cancer Control. 2019 Jan-Dec;26(1):1073274819865281. doi: 10.1177/1073274819865281.

引用本文的文献

1
Rethinking the diagnostic value of thymic CT in ocular myasthenia gravis.重新审视胸腺CT在眼肌型重症肌无力中的诊断价值。
Acta Neurol Belg. 2025 Jun;125(3):853-854. doi: 10.1007/s13760-024-02716-5. Epub 2024 Dec 27.

本文引用的文献

1
Factors affecting minimal manifestation status induction in myasthenia gravis.影响重症肌无力最小表现状态诱导的因素。
Ther Adv Neurol Disord. 2022 Mar 29;15:17562864221080520. doi: 10.1177/17562864221080520. eCollection 2022.
2
Update on Ocular Myasthenia Gravis.眼肌型重症肌无力的最新进展。
Semin Neurol. 2019 Dec;39(6):749-760. doi: 10.1055/s-0039-1700527. Epub 2019 Dec 17.
3
The Value of CT and MRI for Determining Thymoma in Patients With Myasthenia Gravis.CT 和 MRI 对重症肌无力患者胸腺瘤的诊断价值。
Cancer Control. 2019 Jan-Dec;26(1):1073274819865281. doi: 10.1177/1073274819865281.
4
Growth of thymic epithelial tumors and thymic cysts: Differential radiological points.胸腺上皮肿瘤和胸腺囊肿的生长:放射学差异要点。
Thorac Cancer. 2019 Apr;10(4):864-871. doi: 10.1111/1759-7714.13016. Epub 2019 Feb 21.
5
Myasthenia Gravis.重症肌无力
N Engl J Med. 2016 Dec 29;375(26):2570-2581. doi: 10.1056/NEJMra1602678.
6
Normal thymus in adults: appearance on CT and associations with age, sex, BMI and smoking.成人正常胸腺:CT表现及其与年龄、性别、体重指数和吸烟的关系
Eur Radiol. 2016 Jan;26(1):15-24. doi: 10.1007/s00330-015-3796-y. Epub 2015 Apr 30.
7
Long-term outcome of 424 childhood-onset myasthenia gravis patients.424 例儿童起病重症肌无力患者的长期预后。
J Neurol. 2015;262(4):823-30. doi: 10.1007/s00415-015-7638-2. Epub 2015 Jan 15.
8
The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma.胸部计算机断层扫描的形态学特征与胸腺瘤临床特征的相关性
Eur J Cardiothorac Surg. 2015 Nov;48(5):698-704. doi: 10.1093/ejcts/ezu475. Epub 2014 Dec 18.
9
The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ.自身免疫性重症肌无力中的胸腺:三级淋巴器官的范例。
Rev Neurol (Paris). 2013 Aug-Sep;169(8-9):640-9. doi: 10.1016/j.neurol.2013.02.005. Epub 2013 Sep 2.
10
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.不同亚型重症肌无力的发病机制中胸腺的不同作用。
Autoimmun Rev. 2013 Jul;12(9):875-84. doi: 10.1016/j.autrev.2013.03.007. Epub 2013 Mar 25.